Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) - Total Liabilities
Based on the latest financial reports, Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) has total liabilities worth CN¥513.25 Million CNY (≈ $75.10 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 603168 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Zhejiang Shapuaisi Pharmaceutical Co Ltd - Total Liabilities Trend (2008–2024)
This chart illustrates how Zhejiang Shapuaisi Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Zhejiang Shapuaisi Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Shapuaisi Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Orell Fuessli Holding AG
SW:OFN
|
Switzerland | CHF76.26 Million |
|
Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd
SHE:300313
|
China | CN¥243.80 Million |
|
Norwood Financial Corp
NASDAQ:NWFL
|
USA | $2.18 Billion |
|
Austindo Nusantara Jaya Tbk
JK:ANJT
|
Indonesia | Rp184.53 Million |
|
ANTENGENE CORP. DL-0001
F:722
|
Germany | €614.60 Million |
|
Spectral Med Inc
TO:EDT
|
Canada | CA$76.79 Million |
|
Siddhi Acquisition Corp Class A Common stock
NASDAQ:SDHI
|
USA | $16.74 Million |
Liability Composition Analysis (2008–2024)
This chart breaks down Zhejiang Shapuaisi Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Zhejiang Shapuaisi Pharmaceutical Co Ltd market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Shapuaisi Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
The table below shows the annual total liabilities of Zhejiang Shapuaisi Pharmaceutical Co Ltd from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥516.59 Million ≈ $75.59 Million |
+17.16% |
| 2023-12-31 | CN¥440.92 Million ≈ $64.52 Million |
+82.96% |
| 2022-12-31 | CN¥240.99 Million ≈ $35.26 Million |
+3.48% |
| 2021-12-31 | CN¥232.89 Million ≈ $34.08 Million |
-36.51% |
| 2020-12-31 | CN¥366.78 Million ≈ $53.67 Million |
+265.75% |
| 2019-12-31 | CN¥100.28 Million ≈ $14.67 Million |
-40.10% |
| 2018-12-31 | CN¥167.41 Million ≈ $24.50 Million |
-21.08% |
| 2017-12-31 | CN¥212.13 Million ≈ $31.04 Million |
-14.43% |
| 2016-12-31 | CN¥247.88 Million ≈ $36.27 Million |
-35.34% |
| 2015-12-31 | CN¥383.37 Million ≈ $56.10 Million |
+250.29% |
| 2014-12-31 | CN¥109.44 Million ≈ $16.01 Million |
-55.19% |
| 2013-12-31 | CN¥244.26 Million ≈ $35.74 Million |
+0.80% |
| 2012-12-31 | CN¥242.33 Million ≈ $35.46 Million |
+93.19% |
| 2011-12-31 | CN¥125.43 Million ≈ $18.35 Million |
+78.04% |
| 2010-12-31 | CN¥70.45 Million ≈ $10.31 Million |
-8.68% |
| 2009-12-31 | CN¥77.15 Million ≈ $11.29 Million |
+11.42% |
| 2008-12-31 | CN¥69.24 Million ≈ $10.13 Million |
-- |
About Zhejiang Shapuaisi Pharmaceutical Co Ltd
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. Zhejiang Shapuaisi… Read more